跳至主要内容
临床试验/NCT00005660
NCT00005660已完成不适用

The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases

National Cancer Institute (NCI)1 个研究点 分布在 1 个国家目标入组 130 人开始时间: 2000年5月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
130
试验地点
1

研究概览

简要总结

This is a continuing study which evaluates the long-term safety and efficacy of oral acitretin in an open manner in the treatment of psoriasis, cutaneous disorders of keratinization, multiple basal cell carcinomas and other retinoid responsive diseases.

详细描述

This is a continuing study which evaluates the long-term safety and efficacy of oral acitretin in an open manner in the treatment of psoriasis, cutaneous disorders of keratinization, multiple basal cell carcinomas and other retinoid responsive diseases.

研究设计

研究类型
Observational

入排标准

性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究者

申办方类型
Nih

研究点 (1)

Loading locations...

相似试验

The Evaluation of Oral Acitretin in the Treatment of... | 临床试验